JACKSONVILLE, Fla. and IRVINE, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) — Espero BioPharma, Inc., (“Espero”, or “the Company”), a pharmaceutical company focused on the development of late-stage drugs to treat forms of cardiovascular disease, today announced the appointment of Lee Golden, M.D. as Chief Medical Officer. In his role as […]
Financial
Paragonix Technologies Inc., Announces Presentation of the Paragonix SherpaPak™ Cardiac Transport System at Medline Booths 45 and 46 at the 2018 AATB Annual Meeting held from 9 to 12 October 2018
BRAINTREE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. will present the Paragonix SherpaPak™ Cardiac Transport System product line at Medline Industries, Inc. Booths 45 and 46 during the 2018 American Association of Tissue Banks (AATB) Annual Meeting held in Dallas, TX, from 9 to 12 October, 2018. The Paragonix SherpaPak™ CTS1,2 is intended for […]
Cardiovascular Systems, Inc. to Webcast Fiscal 2019 First-Quarter Earnings Conference Call Tuesday, October 30
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2019 first-quarter conference call on Tuesday, October 30, 2019, at 3:45 p.m. CT (4:45 p.m. ET). CSI management will discuss results for its fiscal first quarter ended September 30, 2018, and its financial […]
Interrad Medical Announces Agreement with Vygon to Distribute SecurAcath in France
PLYMOUTH, Minn., USA & ECOUEN, France–(BUSINESS WIRE)–Interrad Medical, a privately held medical device company, announces an agreement with Vygon to distribute the SecurAcath Subcutaneous Catheter Securement Device in France. “As we continue to expand global distribution, we are very excited to be able to enter the French market with Vygon […]
Integer Schedules Third Quarter 2018 Earnings Release and Conference Call for November 1, 2018
PLANO, Texas, Oct. 08, 2018 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR), announced today that it plans to release financial and operational results for third quarter 2018, at 9 a.m. Eastern Time (ET) on Thursday, November 1, 2018. Following the release, Integer management will host a webcast at 9 a.m. […]
Orchestra BioMed™ Bolsters Leadership Team with Appointment of Inessa Wheeler as Vice President, Strategy and Marketing
NEW HOPE, Pa., Oct. 08, 2018 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company developing high impact, high value, evidence based therapeutic solutions for medical procedures that address major medical conditions, announced today that it has appointed Inessa Wheeler, MBA, as Vice President of Strategy […]
Teleflex Acquires Essential Medical
WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX) today announced that it has acquired Essential Medical, Inc. Based in Exton, PA, Essential Medical is a privately-held medical device company that has developed and commercialized the CE Marked MANTA™ Vascular Closure Device specifically designed for closure of large bore arteriotomies following procedures utilizing […]
Acasti Pharma Announces Proposed Underwritten Public Offering of Common Shares
MONTRÉAL, Oct. 03, 2018 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, announced today that it intends to offer and sell its common […]
LuxCath Appoints Terry Ransbury as Chief Technology Officer
BOSTON–(BUSINESS WIRE)–LuxCath, LLC, a medical device company developing a novel cardiac catheter ablation technology, today announced that Terry Ransbury has been appointed its Chief Technology Officer. Mr. Ransbury is a seasoned industry veteran who brings over 30 years of experience in research and development, specializing in electrophysiology and cardiac rhythm […]
AtriCure Announces Proposed Public Offering of Common Stock
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced it has commenced an underwritten public offering of 2.5 million shares of its common stock pursuant to its existing shelf registration statement. In connection with this offering, […]



